Zoetis launches Itch Instinct tool in support
of its K-9 Courage™ Program
Zoetis Inc. (NYSE:ZTS), the leading global animal health
company, today announced that music and television star Nick
Lachey* is teaming up with the company to launch Your Animal
Instinct, a program to help your dog put its best paw forward this
spring. Your Animal Instinct aims to help pet owners understand
when their dog’s itching may be due to an allergy-related skin
condition – and what they can do about it.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170405005681/en/
Nick Lachey plays outside with his dog,
Wookie. Photo: Zoetis.
During the program’s kick-off this spring allergy season, dog
owners are encouraged to take an online itch quiz at
YourAnimalInstinct.com to help them distinguish between their dog’s
normal itch and when frequent scratching, licking, biting, and/or
rubbing could be the sign of allergic skin disease. Completion of
the “Itch Instinct” quiz will trigger a donation made by Zoetis to
expand the number of recipients in its K-9 Courage™ Program, which
provides healthcare assistance to retired military and police dogs,
as well as service dogs that assist veterans suffering from
post-traumatic stress.
“I’m excited to be a part of this program because I know
first-hand how tough it is to witness your dog scratch so much that
he can’t sleep, and all you want to do is help him,” said Lachey,
whose dog, Wookie, was diagnosed with allergic skin disease. “We
tried some creams and antihistamines, which didn’t provide much
relief. When our vet told us what was causing his itch, we were
relieved to find out there was a treatment called Apoquel that
could help him.”
While an occasional itch may be normal for dogs, it should never
interrupt activities such as playing or eating, cause hair loss or
skin damage, or be often enough that it’s bothersome to dogs or
their owners.
“If your dog is frequently or constantly scratching, licking,
biting, scooting and/or rubbing, the underlying cause might be an
allergic skin disease which can lead to additional problems
including infection and severe skin irritation. It’s important to
talk to your veterinarian if your dog is exhibiting this behavior,”
said Dr. Jeff Werber**, veterinary medical journalist and owner and
chief medical director at Century Veterinary Group in Los Angeles.
“The good news is that Zoetis’ revolutionary treatment for allergic
itch, Apoquel, can help your dog in as little as four hours. Unlike
over-the-counter remedies, Apoquel targets your dog’s itch at the
source and provides long-lasting, noticeable relief.”
While it’s common for pet owners to try over-the-counter
treatments such as antihistamines or prescription corticosteroids,
these often do not provide the necessary relief, or may come with
unwanted side effects such as drowsiness, increased panting,
thirst, frequent urination, liver disease and an increased risk of
infection.
Zoetis has an innovative, diverse dermatology portfolio to
address the unique needs of your dog, including two targeted
therapies that provide fast and safe relief. Apoquel® (oclacitinib
tablet) is a daily oral medication that stops allergic itch at the
source for dogs one year of age and older. It works quickly,
in as few as four hours, for all types of allergic dermatitis,
including food and environment allergies, with minimal side
effects. CytopointTM is an injection that provides long-lasting
relief for dogs of all ages with atopic dermatitis (dogs with
allergies due to dust mites, pollens and molds) that is
administered at the veterinarian’s office.
Lachey and Dr. Werber have teamed up with Zoetis to help educate
dog owners about allergic skin disease and treatment, while also
supporting its K-9 Courage™ Program. Dog owners can learn more and
support the program just by taking the itch instinct quiz at
YourAnimalInstinct.com.
About Apoquel
Apoquel was approved by the U.S. Food and Drug Administration in
May 2013 and is the first and only Janus kinase (JAK) inhibitor
approved for veterinary use. Unlike over-the-counter treatments
such as shampoos and antihistamines which do not provide necessary
relief, or corticosteroids which cause short and long term side
effects such as excessive drinking, urination, behavior changes and
can damage the liver, Apoquel is the only treatment specifically
designed to go straight to the source of the itch. Because Apoquel
targets the cause of the itch, it has minimal effect on other
organs and functions. Apoquel starts to relieve the itch within 4
hours and effectively controls the itch within 24 hours. Clinical
studies have shown that Apoquel provides rapid relief from itching
and improves inflammation in dogs that suffer from allergies,
without many of the side effects commonly associated with steroids.
It can be used concomitantly with many other medications and can be
used long term. For more information, please visit
www.apoqueldogs.com.
IMPORTANT SAFETY INFORMATION
Do not use Apoquel in dogs less than 12 months of age or those
with serious infections. Apoquel may increase the chances of
developing serious infections, and may cause existing parasitic
skin infestations or pre-existing cancers to get worse. Apoquel has
not been tested in dogs receiving some medications including some
commonly used to treat skin conditions such as corticosteroids and
cyclosporines. Do not use in breeding, pregnant, or lactating dogs.
Most common side effects are vomiting and diarrhea. Apoquel has
been used safely with many common medications including
parasiticides, antibiotics and vaccines. For more information visit
ZoetisUS.com/ApoquelPI.
About Cytopoint
Cytopoint is a ready-to-use, sterile liquid injectable
containing a monoclonal antibody specifically designed to target
and neutralize cytokine interleukin-31 (IL-31), a key cytokine
(protein important in cell to cell communication) involved in
triggering the itch associated with canine atopic dermatitis.
Cytopoint works by mimicking the activity of natural antibodies to
selectively bind and neutralize IL-31, thus interrupting the itch
cycle in atopic dogs. It begins working within 1 day and delivers 4
to 8 weeks of relief from the clinical signs of canine atopic
dermatitis, allowing the damaged skin the chance to heal. It is
safe for dogs of any age, even those with concomitant diseases, and
can be used with many common medications. For more information,
please visit http://www.cytopoint4dogs.com.
About the K-9 Courage Program
The K-9 Courage Program from Zoetis provides healthcare
assistance to retired police and military dogs as well as service
dogs that assist veterans suffering from Post-Traumatic Stress. In
partnership with the Sage Foundation for Dogs Who Serve, the
National Police Dog Foundation and American Humane, the program
provides the owner of each dog with $300 annually on a debit card
that can be applied toward any veterinary expense ranging from
wellness visits and vaccines to prescription medications and
treats. To learn more, please visit
www.k9couragefromzoetis.com.
About Zoetis
Zoetis is the leading animal health
company, dedicated to supporting its customers and their
businesses. Building on more than 60 years of experience in animal
health, Zoetis discovers, develops, manufactures and markets
veterinary vaccines and medicines, complemented by diagnostic
products, genetic tests, biodevices and a range of services. Zoetis
serves veterinarians, livestock producers and people who raise and
care for farm and companion animals with sales of its products in
more than 100 countries. In 2016, the company generated annual
revenue of $4.9 billion with approximately 9,000 employees. For
more information, visit www.zoetis.com.
*Nick Lachey is a spokesperson for Zoetis**Dr. Jeff Werber is a
consultant for Zoetis
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170405005681/en/
ZoetisColleen White,
973-822-7203colleen.white@zoetis.comorElinore White,
973-443-2835elinore.y.white@zoetis.comorGCI HealthDiana
Bardusk, 312-596-3108diana.bardusk@gcihealth.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024